logo
Select company
Select metric
$ 65.5MCore Assets
VS
Market
22
Sector
46
Industry
52
History
100
$ 15.19Close
$ 9.55 - $ 70 52-Week Range
Ticker Information

Ticker

KROS

Company Name

KEROS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KEROS THERAPEUTICS INC - Core Assets Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KROS - Core Assets Historical data
DateTotal AssetsCash and EquivalentsCore AssetsGoodwill and Intangibles
6/30/2025$ 757.16M$ 691.66M$ 65.5M$ 0
3/31/2025$ 784.56M$ 721.99M$ 62.57M$ 0
12/31/2024$ 615.89M$ 561.38M$ 54.51M$ 0
9/30/2024$ 579.27M$ 532.13M$ 47.14M$ 0
6/30/2024$ 455.02M$ 407.07M$ 47.95M$ 0
3/31/2024$ 485.82M$ 443.65M$ 42.16M$ 0
12/31/2023$ 370.02M$ 332.36M$ 37.67M$ 0
9/30/2023$ 326.25M$ 289.11M$ 37.14M$ 0
6/30/2023$ 356.31M$ 323.35M$ 32.95M$ 0
3/31/2023$ 384.44M$ 352.76M$ 31.68M$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KEROS THERAPEUTICS INC's latest trailing twelve months (TTM) Core Assets stands at $ 4.32M.
  • Over the past 5 years, KEROS THERAPEUTICS INC's average Core Assets has been $ 28M.
  • The median Core Assets for KEROS THERAPEUTICS INC during this period was $ 29.04M
  • KEROS THERAPEUTICS INC reached its highest Core Assets over the past 5 years at $ 65.5M.
  • The lowest Core Assets recorded by KEROS THERAPEUTICS INC in the same timeframe $ 2.41M

KEROS THERAPEUTICS INC's Core Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Core Assets Benchmarks
CompanyCore Assets
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ 304.56MDNA : GINKGO BIOWORKS HOLDINGS INC $ 961.29MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ 463.81MRIGL : RIGEL PHARMACEUTICALS INC $ 127.41MSTOK : STOKE THERAPEUTICS INC $ 282.96MXNCR : XENCOR INC $ 823.44MAKBA : AKEBIA THERAPEUTICS INC $ 149.24MANAB : ANAPTYSBIO INC $ 290.95MRGNX : REGENXBIO INC $ 499.44MPHAT : PHATHOM PHARMACEUTICALS INC $ 97.79M

Definition of Core Assets

[Calculation] The core assets of a company represents the total [Assets] minus cash & equivalents [CashnEq] minus intangibles & goodwill [Intangibles].
Assets - Intangibles - CashnEq
(=) Core Assets
Core Assets for KEROS THERAPEUTICS INC is calculated as follows: Assets [ $ 138.25M ] - Intangibles [ $ 0 ] - CashnEq [ $ 133.93M ]
(=) Core Assets [ $ 4.32M ]

KROS - Core Assets, Last 5 years

$ 2.41M

Minimum

Mar 31, 2021

$ 65.5M

Maximum

Jun 30, 2025

$ 28M

Average

$ 29.04M

Median

Core Assets Benchmark Analysis

The chart above depicts the distribution of Core Assets for companies in the Total Stock Market. The average Core Assets of the companies is $ 798.38M with a standard deviation of $ 1.05B.
The following table provides additional summary stats:
Core Assets in the Market:
filtered constituents3.42K
min$ 0
max$ 4.36B
average$ 798.38M
median$ 287.61M
std$ 1.05B